A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Public ClinicalTrials.gov record NCT07369011. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Moderate to Severe Obstructive Sleep Apnea, and Obesity or Overweight
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity or overweight. YDAO is a master protocol designed to support two independent studies: YSA1 and YSA2. Study YSA1 will include participants who are unable or unwilling to use Positive Airway Pressure (PAP) therapy and study YSA2 will include participants who are on PAP therapy for at least 3 months at time of screening and plan to continue PAP therapy during the study. Participants will be assigned to the Intervention-Specific Appendix (ISA) that reflects their current PAP usage. Participation in the study will last about 76 weeks.
Study identification
- NCT ID
- NCT07369011
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 800 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 9, 2026
- Primary completion
- Feb 29, 2028
- Completion
- Mar 31, 2028
- Last update posted
- Sep 7, 2026
2026 – 2028
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cullman Clinical Trials | Cullman | Alabama | 35055 | Recruiting |
| Ark Clinical Research | Long Beach | California | 90815 | Recruiting |
| Collaborative Neuroscience Research, LLC | Los Alamitos | California | 90720 | Recruiting |
| Artemis Institute for Clinical Research | Riverside | California | 92503 | Recruiting |
| Care Access - Aurora | Aurora | Colorado | 80012 | Recruiting |
| Flourish Research - Miami, LLC | Miami | Florida | 33135 | Recruiting |
| PharmaDev Clinical Research Institute, LLC | Miami | Florida | 33176 | Recruiting |
| Emerald Coast Neurology - Airport Boulevard | Pensacola | Florida | 32504 | Recruiting |
| Teak Research Consults | Lawrenceville | Georgia | 30043 | Recruiting |
| EBGS Clinical Research Center | Snellville | Georgia | 30078 | Recruiting |
| Care Access - Shreveport 2 | Shreveport | Louisiana | 71105 | Recruiting |
| Flourish Research - Bowie | Bowie | Maryland | 20715 | Recruiting |
| Revive Research Institute, Inc. | Southfield | Michigan | 48075 | Recruiting |
| Headlands Research-Twin Cities | Maplewood | Minnesota | 55109 | Recruiting |
| Clayton Sleep Institute - St. Louis - Tesson Ferry Road | St Louis | Missouri | 63123 | Recruiting |
| Palm Research Center Tenaya | Las Vegas | Nevada | 89128 | Recruiting |
| The Sleep Spot - Maimonides | Albuquerque | New Mexico | 87107 | Recruiting |
| Rochester Clinical Research - Buffalo | Buffalo | New York | 14127 | Recruiting |
| CTI Clinical Research Center | Cincinnati | Ohio | 45212 | Recruiting |
| Bogan Sleep Consultants | Columbia | South Carolina | 29201 | Recruiting |
| FutureSearch Trials of Neurology | Austin | Texas | 78731 | Recruiting |
| Sleep Therapy Research Center | San Antonio | Texas | 78229 | Recruiting |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07369011, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 7, 2026 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07369011 live on ClinicalTrials.gov.